Neuracle Science
- Biotech or pharma, therapeutic R&D
Neuracle Science is a clinical-stage biotechnology company dedicated to translating groundbreaking scientific discoveries into novel therapies for neurological diseases, particularly those characterized by impaired synaptic structure and function known as synaptopathy.
NS101 is our first-in-class monoclonal antibody targeting synaptopathy diseases, including sensorineural hearing loss (SNHL), frontotemporal dementia (FTD), and Alzheimer's disease (AD).
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}